Ranolazine
NDC 90096-151, ranolazine, tablet, film coated, extended release, from Zameer Pharmaceuticals LLC.
- Product NDC
- 90096-151
- Status
- Listed
- Labeler
- Zameer Pharmaceuticals LLC
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213085
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/90096-151 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RANOLAZINE500 mg/1
Pharmacologic classes
Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 90096-151-60 | 90096015160 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (90096-151-60) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/5f4fc8a4-2bd5-4378-8882-e739c951390eNADAC price for package 90096015160
GET /v1/drugs/nadac/90096015160
Use it
Look up 90096-151 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/90096-151 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 90096-151. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.